ClearBridge Investments' third-quarter 2025 investor letter discusses the performance of their Small Cap Growth Strategy, which underperformed the benchmark. A notable stock highlighted is Avidity Biosciences, Inc.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing